For retail sale medicaments with penicillins or streptomycins market in Poland

Earlier Report Observations

The retail market for penicillin and streptomycin medicaments in Poland experienced significant fluctuations between 2018 and 2023. After starting at 124 069 thousand USD in 2018, the market size contracted to 104 914 thousand USD in 2019 and further to 95 325 thousand USD in 2020. It stabilized around 95 227 thousand USD in 2021 before recovering to 102 174 thousand USD in 2022, then eased slightly to 99 532 thousand USD in 2023.

Domestic production followed a similar pattern, declining from 66 655 thousand USD in 2018 to 61 777 thousand USD in 2020, then rising to 65 388 thousand USD in 2022 before a sharp drop to 48 947 thousand USD in 2023. Meanwhile, exports grew steadily from 9 619 thousand USD in 2018 to 29 595 thousand USD in 2023, reflecting increasing international sales.

In 2024, the European market for these antibiotics saw rising demand driven by the need for effective and affordable treatments. Investments in new production capacity, such as the opening of Sandoz's antibiotic plant in Austria, along with legislative changes in the EU regarding labeling and tracking, and evolving consumer preferences towards broad-spectrum antibiotics like amoxicillin, shaped the market environment in Poland.

Production for retail sale medicaments with penicillins or streptomycins in Poland

In value, 2017-2020, K $ US

In Poland, the production of retail sale medicaments containing penicillins or streptomycins declined for the second consecutive year. In 2020, output was valued at 61 777 K $ US, marking a 1.1% drop compared to 2019. The largest decline occurred in 2019, at 6.3%, while the largest increase was recorded in 2018, at 7.2%. The peak value was reached in 2018, at 66 655 K $ US.

Annual dynamics of production in Poland in value, 2017-2020, K $ US

Exports for retail sale medicaments with penicillins or streptomycins from Poland

Exports in kind, t

After a two-year rise, Poland's exports of retail sale medicaments with penicillins or streptomycins declined. In 2020, exports amounted to 551 t, indicating a 10.8% decrease from the previous year. The maximum value was recorded in 2019, at 618 t, with the largest increase that year at 68.0%. Over the period from 2017 to 2020, exports grew by 133%, corresponding to a compound annual growth rate (CAGR) of 32.6%.

Annual dynamics of product's exports from Poland in kind, 2017-2020, t

From 2017 to 2020, the structure of exports in kind was characterized by Russia's dominance, absorbing 82.9% of total flows, alongside a large number of minor trading partners.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Poland in kind, 2017-2020

Exports in value, K $ US

For the second consecutive year, Poland's exports of retail sale medicaments with penicillins or streptomycins increased. In 2020, exports were valued at 12 656 K $ US, representing a significant gain of 12.9% compared to the previous year. The largest increase occurred in 2019, at 16.5%, while the largest decline was in 2018, at 6.6%. The minimum value was recorded in 2018, at 9 619 K $ US. Between 2017 and 2020, exports rose by 22.9%, equating to an annualized rate of 7.1%.

Annual dynamics of product's exports from Poland in value, 2017-2020, K $ US

From 2017 to 2020, Russia, Czechia, and Vietnam were the key destinations for exports in value terms, accounting for 49.3%, 22.5%, and 5.4% of total flows, respectively. Together, they represented 77.2% of all exports.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Poland in value, 2017-2020

Imports for retail sale medicaments with penicillins or streptomycins to Poland

Imports in kind, t

In 2020, Poland's imports of retail sale medicaments with penicillins or streptomycins amounted to 956 t, showing a modest rise of 6.1% relative to the prior year. The minimum value was recorded in 2019, at 901 t, with the largest decline that year at 17.5%. The maximum value was in 2018, at 1 091 t, when the largest increase occurred at 8.4%. Between 2017 and 2020, imports decreased by 5.1%, corresponding to an annualized rate of 1.7%.

Annual dynamics of product's imports to Poland in kind, 2017-2020, t

Over the period from 2017 to 2020, Austria, France, and Slovenia were the leading sources in the country structure of imports in kind, with shares of 23.5%, 21.7%, and 15.1%, respectively. Combined, they accounted for 60.3% of total import flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Poland in kind, 2017-2020

Imports in value, K $ US

For the second consecutive year, Poland's imports of foreign retail sale medicaments with penicillins or streptomycins declined. In 2020, imports amounted to 46 204 K $ US, which is 13.9% smaller compared to 2019. The largest decline was recorded in 2019, at 19.9%, while the largest increase occurred in 2018, at 11.9%. The peak value was reached in 2018, at 67 033 K $ US. Between 2017 and 2020, imports fell by 22.9%, equating to an annualized rate of 8.3%.

Annual dynamics of product's imports to Poland in value, 2017-2020, K $ US

Throughout 2017 to 2020, France, Slovenia, and Austria formed the core group of markets for imports in value terms, with shares of 33.5%, 14.4%, and 13.3%, respectively. Together, they represented 61.2% of total import flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Poland in value, 2017-2020